AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (July 5, 2006). doi:10.1152/ajpendo.00207.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/5/E867    most recent
00207.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujii, N.
Right arrow Articles by Goodyear, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujii, N.
Right arrow Articles by Goodyear, L. J.
Submitted on April 28, 2006
Accepted on June 26, 2006

AMP-activated Protein Kinase and the Regulation of Glucose Transport

Nobuharu Fujii1, Niels Jessen2, and Laurie J. Goodyear1*

1 Research Division, Joslin Diabetes Center and Department Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States
2 Research Division, Joslin Diabetes Center and Department Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States; Medical Research Laboratory and Department of Clinical Pharmacology, University of Aarhus, Aarhus, Denmark

* To whom correspondence should be addressed. E-mail: laurie.goodyear{at}joslin.harvard.edu.

The AMP-activated protein kinase (AMPK) is an energy-sensing enzyme that is activated by acute increases in the cellular [AMP]:[ATP] ratio. In skeletal and/or cardiac muscle, AMPK activity is increased by stimuli such as exercise, hypoxia, ischemia, and osmotic stress. There are many lines of evidence that increasing AMPK activity in skeletal muscle results in increased rates of glucose transport. Although similar to the effects of insulin to increase glucose transport in muscle, it is clear that the underlying mechanisms for AMPK- mediated glucose transport involve proximal signals that are distinct from that of insulin. Here, we discuss the evidence for AMPK regulation of glucose transport in skeletal and cardiac muscle, and describe research investigating putative signaling mechanisms mediating this effect. We also discuss evidence that AMPK may play a role in enhancing muscle and whole body insulin sensitivity for glucose transport under conditions such as exercise, as well as the use of the AMPK activator AICAR to reverse insulin resistant conditions. The identification of AMPK as a novel glucose transport mediator in skeletal muscle is providing important insights for the treatment and prevention of type 2 diabetes.




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich
Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species
Physiol Rev, January 1, 2009; 89(1): 27 - 71.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Nieto-Vazquez, S. Fernandez-Veledo, C. de Alvaro, and M. Lorenzo
Dual Role of Interleukin-6 in Regulating Insulin Sensitivity in Murine Skeletal Muscle
Diabetes, December 1, 2008; 57(12): 3211 - 3221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Lefort, E. St.-Amand, S. Morasse, C. H. Cote, and A. Marette
The {alpha}-subunit of AMPK is essential for submaximal contraction-mediated glucose transport in skeletal muscle in vitro
Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1447 - E1454.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Fujii, R. C. Ho, Y. Manabe, N. Jessen, T. Toyoda, W. L. Holland, S. A. Summers, M. F. Hirshman, and L. J. Goodyear
Ablation of AMP-Activated Protein Kinase {alpha}2 Activity Exacerbates Insulin Resistance Induced by High-Fat Feeding of Mice
Diabetes, November 1, 2008; 57(11): 2958 - 2966.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Nedachi, H. Fujita, and M. Kanzaki
Contractile C2C12 myotube model for studying exercise-inducible responses in skeletal muscle
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1191 - E1204.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. J. Pedersen, S. J. Lessard, V. G. Coffey, E. G. Churchley, A. M. Wootton, T. Ng, M. J. Watt, and J. A. Hawley
High rates of muscle glycogen resynthesis after exhaustive exercise when carbohydrate is coingested with caffeine
J Appl Physiol, July 1, 2008; 105(1): 7 - 13.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. Kaddai, T. Gonzalez, M. Bolla, Y. Le Marchand-Brustel, and M. Cormont
The nitric oxide-donating derivative of acetylsalicylic acid, NCX 4016, stimulates glucose transport and glucose transporters translocation in 3T3-L1 adipocytes
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E162 - E169.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. J. Zhu, B. Han, J. Tong, C. Ma, J. M. Kimzey, K. R. Underwood, Y. Xiao, B. W. Hess, S. P. Ford, P. W. Nathanielsz, et al.
AMP-activated protein kinase signalling pathways are down regulated and skeletal muscle development impaired in fetuses of obese, over-nourished sheep
J. Physiol., May 15, 2008; 586(10): 2651 - 2664.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
M. Lorenzo, S. Fernandez-Veledo, R. Vila-Bedmar, L. Garcia-Guerra, C. De Alvaro, and I. Nieto-Vazquez
Insulin resistance induced by tumor necrosis factor-{alpha} in myocytes and brown adipocytes
J Anim Sci, April 1, 2008; 86(14_suppl): E94 - E104.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. B. Yaspelkis III, S. J. Lessard, D. W. Reeder, J. J. Limon, M. Saito, D. A. Rivas, I. Kvasha, and J. A. Hawley
Exercise reverses high-fat diet-induced impairments on compartmentalization and activation of components of the insulin-signaling cascade in skeletal muscle
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E941 - E949.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
V. A. Lira, Q. A. Soltow, J. H. D. Long, J. L. Betters, J. E. Sellman, and D. S. Criswell
Nitric oxide increases GLUT4 expression and regulates AMPK signaling in skeletal muscle
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1062 - E1068.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. S. Jeyapalan, R. A. Orellana, A. Suryawan, P. M. J. O'Connor, H. V. Nguyen, J. Escobar, J. W. Frank, and T. A. Davis
Glucose stimulates protein synthesis in skeletal muscle of neonatal pigs through an AMPK- and mTOR-independent process
Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E595 - E603.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
H. F. Kramer and L. J. Goodyear
Exercise, MAPK, and NF-{kappa}B signaling in skeletal muscle
J Appl Physiol, July 1, 2007; 103(1): 388 - 395.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
C. Chabrolle, L. Tosca, and J. Dupont
Regulation of adiponectin and its receptors in rat ovary by human chorionic gonadotrophin treatment and potential involvement of adiponectin in granulosa cell steroidogenesis
Reproduction, April 1, 2007; 133(4): 719 - 731.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.